No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
AU Stock MarketDetailed Quotes
TYP Tryptamine Therapeutics Ltd
- 0.020
- -0.001-4.76%
20min DelayNot Open Jul 1 15:14 AET
23.78MMarket Cap-219P/E (Static)
0.021High0.020Low54.38KVolume0.021Open0.021Pre Close1.11KTurnover0.02752wk High0.01%Turnover Ratio1.19BShares0.01952wk Low-0.038EPS TTM17.11MFloat Cap0.027Historical HighLossP/E (Static)855.44MShs Float0.019Historical Low-0.091EPS LYR4.76%Amplitude--Dividend TTM10.00P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Tryptamine Therapeutics Doses First Patient in Intravenous Psilocin Volunteer Study
Tryptamine Therapeutics Achieves Milestone of World's First IV-infused Psilocin Dosing
Tryptamine Therapeutics Completes Maiden Dosing of IV Psilocin – a Global First
Tryptamine Therapeutics Partners With Lucid Health to Advance TRP-8803's Product Registration in Australia
Tryptamine Therapeutics Begins to Trade on ASX; Shares Surge 118%
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg